News

Article

Man suffers bee sting that leaves stinger lodged in eye

Author(s):

Ophthalmologists were able to remove the stinger after identifying its location during a slit lamp examination.

(Image Credit: AdobeStock/borislav15)

(Image Credit: AdobeStock/borislav15)

Getting stung by a bee can be a painful experience, and for some people who are allergic to the venom of the sting, it can lead to anaphylactic shock, rhabdomyolysis, or renal failure. It can be even worse if the person is stung in the eye.

A 55-year-old man presented at an ophthalmology clinic after suffering a sting to the right eye. The case was published in the New England Journal of Medicine.

Immediately after being stung, the man went to a local emergency department where the stinger was removed, but vision issues persisted.

According to the paper, written by Talia N. Shoshany, MD, and Zeba A. Syed, MD, both with the Wills Eye Hospital in Philadelphia, Pennsylvania, the man came to the clinic after experiencing worsening vision and pain in his right eye after having been stung by a bee in that eye 2 days earlier.1

A slit lamp examination was performed to determine the location of the remnants of the stinger.

During an examination, it was noted that vision in the patient’s right eye was limited to counting fingers. The intraocular pressure in the right eye was 16 mm Hg (reference range, 12 to 21). The slit-lamp examination with fluorescein dye was performed, showing conjunctival injection, inferior corneal edema, and an infiltrate at the nasal limbus with a piece of retained stinger.1

The authors noted that a hyphema, which was attributed to iris trauma from the buried stinger and bleeding iris vessels, was detected. Jeweler’s forceps were used to remove the remnants of the stinger.

“Ocular bee stings warrant referral to an ophthalmologist owing to the severe inflammation that may result from the injury, as well as the possibility of a retained stinger in the eye,” the authors concluded.

The patient was prescribed topical antibacterial and prednisolone eye drops were prescribed. At 5 months of follow-up, the visual acuity in the right eye had improved to 20/25.

Reference:
  1. Talia N. Shoshany, MD, and Zeba A. Syed, MD. Ocular Bee Sting. N Engl J Med. Published June 22, 2024. Accessed July 8, 2024. DOI: 10.1056/NEJMicm2400652

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.